Almirall joins FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants
Almirall brings its experience in privacy matters and pharmaceutical law, as well as in the development of guidance, standards, and recommendations for returning clinical trials data to patients The project will last four years and involves 27 partners from 16 EU and extra-EU Member States, including patient associations, hospitals, universities, SMEs,Continue Reading